Ozmosi | SNAP-40 Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

SNAP-40

Alternative Names: snap-40, snap40, snap 40
Clinical Status: Inactive
Latest Update: 2021-11-03
Latest Update Note: Clinical Trial Update

Product Description

Non-invasive, wearable armband device used to measure change in systolic blood pressure, respiratory rate, heart rate, body temperature, movement, and oxyhemoglobin saturation and streams this information to a cloud-based storage system. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT03800329)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Unknown

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Mayo Clinic
Company Location: Eastern America
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated

NCT03800329

NCT03800329

N/A

Completed

Other

2021-10-26

2021-11-04

Primary Endpoints

NCT03179267

SNAP40ED

N/A

Completed

Hypertension|Weight Gain

2017-12-22

2019-03-21

Treatments

Recent News Events

Date

Type

Title